Neoadjuvant tislelizumab with afatinib for locally advanced head and neck squamous cell carcinoma (neoCHANCE-1): a phase 2 clinical trial
- Zhi-gong Wei
- Hui-jiao Chen
- De-juan Wang
- Zheng Jiang
- Yi-yan Pei
- Le-yu Li
- Feng Wang
- Jing Jin
- Zhe-ran Liu
- Fei Chen
- Jun Liu
- Xing-chen Peng
2025-10-07